Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Escalated Adaptive RadioTherapy - a Randomised Phase II Study of Definitive Chemo-radiotherapy in Locally Advanced Esophageal Cancer

NCT04086901 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT04086901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04086901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Escalated Adaptive RadioTherapy - a Randomised Phase II Study of Definitive Chemo-radiotherapy in Locally Advanced Esophageal Cancer
Lead sponsor
University of Aarhus
Phase
Not applicable
Overall status
Terminated
Start date
January 1, 2020
Completion date
March 1, 2021
Enrollment
3 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer